721,636 Shares in Kenvue Inc. $KVUE Acquired by Corient Private Wealth LP

Key Points

• Corient Private Wealth LP acquired 721,636 Kenvue shares in the second quarter, valued at approximately $9.6 million. Institutional investors collectively own 97.64% of the company, with BlackRock and Pentwater also establishing significant positions.
• Kenvue’s stock opened at $19.15, near its 50-day average, while its market capitalization stood at $36.78 billion. The company’s latest quarterly results slightly missed estimates, reporting $0.31 in EPS and $3.96 billion in revenue, though revenue increased 3% year over year.
• Kenvue maintains a quarterly dividend of $0.21 per share, equivalent to an annualized yield of about 4.4%. Analysts have a consensus “Hold” rating and an average price target of $19.27.

Corient Private Wealth LP purchased a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 721,636 shares of the company's stock, valued at approximately $9,627,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. acquired a new position in Kenvue during the second quarter worth about $2,882,279,000. State Street Corp raised its position in Kenvue by 3.5% in the fourth quarter. State Street Corp now owns 118,865,134 shares of the company's stock worth $2,050,424,000 after acquiring an additional 4,063,257 shares in the last quarter. Pentwater Capital Management LP acquired a new stake in Kenvue in the 2nd quarter valued at about $977,094,000. Geode Capital Management LLC lifted its holdings in Kenvue by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 49,862,574 shares of the company's stock valued at $856,778,000 after acquiring an additional 371,322 shares during the last quarter. Finally, Independent Franchise Partners LLP boosted its position in shares of Kenvue by 56.3% during the 4th quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company's stock valued at $830,527,000 after purchasing an additional 17,343,785 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Kenvue Trading Down 0.1%

NYSE:KVUE opened at $19.15 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.82. The stock's 50-day moving average is $19.16 and its two-hundred day moving average is $18.25. The stock has a market cap of $36.78 billion, a PE ratio of 22.01, a price-to-earnings-growth ratio of 1.37 and a beta of 0.47.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion during the quarter, compared to analysts' expectations of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm's quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.29 EPS. As a group, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 4.4%. This is a positive change from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 12th. Kenvue's dividend payout ratio is currently 96.55%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Weiss Ratings raised Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Zacks Research lowered shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. UBS Group decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Tuesday, August 11th. Barclays lifted their target price on shares of Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Finally, Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source